Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.35 -0.15 (-6.00%)
Closing price 10/10/2025 04:00 PM Eastern
Extended Trading
$2.36 +0.01 (+0.26%)
As of 10/10/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. CHEK, XAIR, OSRH, MHUA, SINT, FEMY, LFWD, LYRA, TNON, and PAVM

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Check-Cap (CHEK), Beyond Air (XAIR), OSR (OSRH), Meihua International Medical Technologies (MHUA), Sintx Technologies (SINT), Femasys (FEMY), Lifeward (LFWD), Lyra Therapeutics (LYRA), Tenon Medical (TNON), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry.

Venus Concept vs. Its Competitors

Check-Cap (NASDAQ:CHEK) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, Venus Concept had 1 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Venus Concept and 2 mentions for Check-Cap. Venus Concept's average media sentiment score of 0.96 beat Check-Cap's score of 0.95 indicating that Venus Concept is being referred to more favorably in the news media.

Company Overall Sentiment
Check-Cap Positive
Venus Concept Positive

Check-Cap has a net margin of 0.00% compared to Venus Concept's net margin of -68.77%. Check-Cap's return on equity of 0.00% beat Venus Concept's return on equity.

Company Net Margins Return on Equity Return on Assets
Check-CapN/A N/A N/A
Venus Concept -68.77%-871.77%-61.92%

Check-Cap has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Check-Cap
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Venus Concept
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

1.1% of Check-Cap shares are held by institutional investors. Comparatively, 87.4% of Venus Concept shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Comparatively, 28.0% of Venus Concept shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Check-Cap has higher earnings, but lower revenue than Venus Concept. Check-Cap is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Check-CapN/AN/A-$25.15M-$3.00-0.61
Venus Concept$64.83M0.05-$47M-$50.78-0.05

Summary

Check-Cap and Venus Concept tied by winning 6 of the 12 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.56M$7.00B$6.10B$10.63B
Dividend YieldN/A1.16%5.67%4.71%
P/E Ratio-0.0526.2985.2726.57
Price / Sales0.05192.73612.78132.63
Price / CashN/A22.0238.5062.09
Price / Book0.555.1112.726.53
Net Income-$47M$178.04M$3.30B$275.96M
7 Day Performance2.17%-2.10%0.94%-0.74%
1 Month Performance1.29%5.62%6.34%3.71%
1 Year Performance-55.46%23.63%80.41%37.30%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
1.0891 of 5 stars
$2.35
-6.0%
N/A-50.5%$3.56M$64.83M-0.05410Analyst Forecast
Short Interest ↑
Gap Down
CHEK
Check-Cap
0.213 of 5 stars
$2.17
-7.5%
N/A+24.3%$12.67MN/A-0.7280Negative News
Analyst Forecast
XAIR
Beyond Air
4.1992 of 5 stars
$2.34
-4.5%
$11.00
+370.1%
-61.6%$12.24M$3.70M-0.2070
OSRH
OSR
N/A$0.54
+2.4%
N/AN/A$11.55M$104.74K0.00N/AAnalyst Forecast
MHUA
Meihua International Medical Technologies
0.8538 of 5 stars
$0.36
-4.1%
N/A-48.0%$11.49M$89.55M0.00620Analyst Forecast
Gap Up
SINT
Sintx Technologies
1.9826 of 5 stars
$4.14
+0.1%
$25.00
+504.6%
+33.5%$11.43M$2.89M-0.0840Analyst Forecast
Gap Up
FEMY
Femasys
2.9448 of 5 stars
$0.35
-0.3%
$7.33
+1,989.3%
-45.3%$11.37M$1.89M-0.4130Analyst Forecast
Gap Up
LFWD
Lifeward
2.4492 of 5 stars
$0.72
-3.4%
$9.00
+1,158.7%
-75.4%$11.23M$25.66M-0.2360Analyst Forecast
LYRA
Lyra Therapeutics
3.0249 of 5 stars
$6.48
-0.3%
$100.00
+1,443.2%
-31.1%$10.63M$1.53M-0.2250Analyst Forecast
Gap Down
TNON
Tenon Medical
2.081 of 5 stars
$1.18
-0.4%
$5.50
+368.1%
-68.3%$10.43M$2.95M-0.048Analyst Forecast
PAVM
PAVmed
4.1114 of 5 stars
$0.44
-2.7%
$19.00
+4,267.8%
-58.2%$9.54M$2.99M0.3890Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 10/11/2025 by MarketBeat.com Staff
From Our Partners